Christine Ortiz
Known title: DirectorCIK: 0001764692
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
Goldman Sachs Lowers Mueller Water Products Target to $24. Goldman Sachs has kept a neutral stance on Mueller Water Products but cut its price target to $24. Other analysts highlighted the company as a cash‑producing stock and noted its solid interest coverage, which may appeal to traders seeking stable earnings. The new target is below the current trading level and near the 20‑touch support at $24.90. These updates could influence how traders view the stock’s valuation.
Transaction History
| ENOV | ▲ Buy | Grant | 958 | $0 | 9/30/2026 | View on chart |
| MWA | ▼ Sell | Open Market | 550 | $13K | 9/1/2026 | View on chart |
| MWA | ▼ Sell | Open Market | 12,048 | $292K | 8/31/2026 | View on chart |
| ENOV | ▲ Buy | Grant | 846 | $0 | 6/30/2026 | View on chart |
| ENOV | ▲ Buy | Grant | 9,346 | $0 | 5/19/2026 | View on chart |
| ENOV | ▲ Buy | Grant | 770 | $0 | 3/31/2026 | View on chart |
| MWA | ▲ Buy | Grant | 4,381 | $0 | 2/9/2026 | View on chart |
| ENOV | ▲ Buy | Grant | 6,598 | $0 | 5/21/2025 | View on chart |
| MWA | ▼ Sell | Open Market | 3,875 | $100K | 3/3/2025 | View on chart |
| MWA | ▲ Buy | Grant | 4,672 | $0 | 2/6/2025 | View on chart |
| MWA | ▼ Sell | Open Market | 8,800 | $175K | 8/14/2024 | View on chart |
| ENOV | ▲ Buy | Grant | 4,338 | $0 | 5/20/2024 | View on chart |
| MWA | ▲ Buy | Grant | 7,376 | $0 | 2/28/2024 | View on chart |
| ENOV | ▲ Buy | Grant | 1,875 | $0 | 5/16/2023 | View on chart |
| MWA | ▲ Buy | Grant | 8,267 | $0 | 2/7/2023 | View on chart |
| ENOV | ▲ Buy | Grant | 396 | $0 | 6/7/2022 | View on chart |
| ENOV | ▲ Buy | Grant | 1,648 | $0 | 6/7/2022 | View on chart |
| MWA | ▲ Buy | Grant | 8,825 | $0 | 2/7/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
Enovis joins AAOS Registry Program as industry sponsor
Enovis has become the first multi-registry industry sponsor of the AAOS Registry Program. This move highlights the company's engagement with major orthopedic data initiatives. The stock is currently trading near its 52-week low, with an average analyst target of $38.33.
Enovis joins AAOS Registry Program as industry sponsor. Enovis has become the first multi-registry industry sponsor of the AAOS Registry Program. This move highlights the company's engagement with major orthopedic data initiatives. The stock is currently trading near its 52-week low, with an average analyst target of $38.33.